Stockscreener 앱 받기
2.00
0.99%
-0.02
전일 마감가:
$2.02
열려 있는:
$2.02
하루 거래량:
2,451
Relative Volume:
0.02
시가총액:
$5.18M
수익:
$102.80K
순이익/손실:
$-5.32M
주가수익비율:
-0.5263
EPS:
-3.8
순현금흐름:
$-5.45M
1주 성능:
+1.01%
1개월 성능:
+1.52%
6개월 성능:
-20.63%
1년 성능:
-55.06%
1일 변동 폭
$1.99
$2.0596
1주일 범위
$1.9442
$2.08
52주 변동 폭
$1.69
$6.90
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
명칭
Creative Medical Technology Holdings Inc
전화
480-399-2822
주소
211 E. OSBORN RD., PHOENIX
CELZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.00 | 5.11M | 102.80K | -5.32M | -5.45M | -3.80 |
|
ONC
Beigene Ltd Adr
|
231.22 | 25.21B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.32 | 112.83B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.285 | 40.72M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.72 | 62.15B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.45 | 5.75B | 0 | -153.72M | -103.81M | -2.00 |
Creative Medical Technology Holdings Inc 주식(CELZ)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: Flora Growth (FLGC), Cardinal Health (CAH) and Zevra Therapeutics (ZVRA) - The Globe and Mail
Creative Medical Technology Holdings: Initiating Coverage With A Sell Rating - Seeking Alpha
$12+ Bn Chronic Lower Back Pain Market Opportunities and - GlobeNewswire
Creative Medical Technology Holdings Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Creative Medical Technology Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Creative Medical Technology Holdings Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain - Barchart.com
Degenerative Disc Disease Treatment Market Size in 7MM - openPR.com
Creative Medical Technology (CELZ) Projected to Post Earnings on Friday - Defense World
Exosome Cell and Gene Therapy Market Deep Research with Forecast - openPR.com
Companies Like Creative Medical Technology Holdings (NASDAQ:CELZ) Are In A Position To Invest In Growth - Yahoo
Creative Science, a CIMA Animal Health Company, Acquires Astaria Global - Yahoo Finance
Mergers & Acquisitions Tracker - Plastics News
Creative Foam buys medical supplier AccuMed from Lear - Plastics News
Venus Shines Again, ENZ To Be Delisted, SLP, CERT On Watch - RTTNews
Head-To-Head Contrast: Atara Biotherapeutics (NASDAQ:ATRA) and Creative Medical Technology (NASDAQ:CELZ) - Defense World
Exosomes Drug Market Projected To Witness Substantial Growth, - openPR.com
Longevity Health to combine with 20/20 BioLabs in all-stock deal (XAGE:NASDAQ) - Seeking Alpha
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Exosomes Market Detailed In New Research Report 2025 | Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC - newstrail.com
CELZ stock touches 52-week low at $1.9 amid market challenges - Investing.com Canada
CELZ stock touches 52-week low at $1.9 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders - MSN
Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews
Reviewing MiNK Therapeutics (NASDAQ:INKT) & Creative Medical Technology (NASDAQ:CELZ) - The AM Reporter
Creative Medical Technology (NASDAQ:CELZ) versus Immunocore (NASDAQ:IMCR) Head to Head Comparison - Defense World
CELZ stock touches 52-week low at $1.95 amid market challenges - Investing.com Australia
CELZ stock touches 52-week low at $1.95 amid market challenges By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Creative Medical Technology (CELZ) to Release Quarterly Earnings on Friday - The AM Reporter
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is Roth Capital’s Forecast for CELZ FY2027 Earnings? - Defense World
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
FDA approves expanded trial for back pain cell therapy By Investing.com - Investing.com South Africa
Creative Medical Technology Holdings Secures FDA Clearance For Expanded Dosing In Back Pain Trial - Nasdaq
FDA approves expanded trial for back pain cell therapy - Investing.com India
Creative Medical Receives FDA Approval to Expand Dosing in Back Pain Trial -March 20, 2025 at 08:27 am EDT - MarketScreener
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain - The Manila Times
Nanoparticle Drug Delivery Market Growth, Generated - openPR.com
Creative Medical Technology Holdings Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Game-Changing: Family-Owned Business Thrives for Over a Century - GeeksULTD
Just Revealed: Crescent Market Beaumont Family-Owned for 100+ Years - GeeksULTD
Apple Stock Forecast: Where Will It Be In 5 Years? - GeeksULTD
Revolutionary: Stem Cell Therapy Puts Creative Medical on Profit Track - GeeksULTD
Sexual Assault in South Sudan: Experts Stunned by Breakthrough Technology - GeeksULTD
Creative Medical Technology Holdings, Inc.'s (NASDAQ:CELZ) Shift From Loss To Profit - Yahoo
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Simply Wall St
Delaware Court Just Changed the Game for Big Business - GeeksULTD
Shocking: Trump Tariffs Spark Market Sell-Off - GeeksULTD
Trump Tariffs in Chaos: Markets React - GeeksULTD
Creative Medical Technology Holdings Inc (CELZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Creative Medical Technology Holdings Inc 주식 (CELZ) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Finger Michael H. | Director |
Feb 18 '25 |
Sale |
5.00 |
750 |
3,750 |
1,101 |
2.34%
1.04%
자본화:
|
볼륨(24시간):